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Liquid spray and aerosol mass vaccination of poultry has several drawbacks such as uncontrolled 26 
deposition of vaccine particles in the respiratory tract and vaccine virus inactivation by formation 27 
and evaporation of droplets, which may be addressed using dry powder vaccines with defined 28 
particle size distributions targeting the upper (primary vaccination) or the entire respiratory tract 29 
(booster vaccination). Therefore, a coarse ND (LZ58 strain) powder vaccine were administered to 30 
SPF broiler hens to compare the seroresponse and adverse vaccinal reactions with those induced 31 
by a coarse liquid spray and a fine liquid aerosol. Groups of 40 broilers each, housed in isolators 32 
were vaccinated at 4 days of age and were intratracheally inoculated with Escherichia coli (strain 33 
506) at 11 days of age. Adverse vaccinal reactions were evaluated by body weight gain and 34 
mortality between 4 and 11 days of age and between 11 and 18 days of age, and by colibacillosis 35 
lesions at 18 days of age. The antibody serum response was measured at 18 days of age by 36 
haemagglutination inhibition test. Despite the relative low initial vaccine virus loss and narrow 37 
particle size distribution of the powder vaccines in comparison with their liquid counter parts, no 38 
significant differences (P >0.05) regarding adverse vaccinal reactions and serum response were 39 
observed between broilers vaccinated with the powder vaccines or with their liquid counterparts. 40 




Vaccination of commercial poultry against Newcastle disease (ND) and other respiratory 43 
diseases is often performed by coarse liquid spray and fine liquid aerosol. Both, protection and 44 
adverse post vaccinal reactions (further referred to as vaccinal reactions) increase as vaccine 45 
loaded particles become smaller (Corbanie et al., 2008; Gough & Allan, 1973; Meszaros et al., 46 
1992; Van Eck & Goren, 1991). To avoid severe vaccinal reactions coarse spray, intended to target 47 
the upper respiratory tract, is therefore used for primary vaccinations, while fine aerosol 48 
vaccinations, intended to reach the lower respiratory tract, are administrated as booster. Particles 49 
with a size >5 µm and >10 µm were hardly deposited in the lower respiratory tract (longs and 50 
thoracic airsacs) of 2- and 4-week-old broilers, respectively. These so-called cut-off particle sizes 51 
were defined as the smallest particle of which less than 5 volume percent (volume percentage(s) 52 
is further referred to as percentage(s) unless otherwise stated) is deposited in the lower respiratory 53 
tract. A reliable cut-off value for day-old chicks could not be assessed as these birds were breathing 54 
with open beaks (Corbanie et al., 2006). 55 
Spray and aerosol are relatively simple and cheap mass vaccination techniques, but have a 56 
number of drawbacks. Currently used spray and aerosol equipment generate broad droplet size 57 
distributions, which often results in severe vaccinal reactions when small droplets of a primary 58 
coarse spray vaccine are inhaled into the lower airways of young chickens (Giambrone, 1981, 59 
1985; Van Eck & Goren, 1991), or in reduced deposition in the lower airways during secondary 60 
fine aerosol vaccination due to the presence of non-respirable droplets (e.g. droplet size spectra 61 
ranging between 10 and 1000 µm (Cargill, 1999)). Furthermore, the efficiency of vaccines 62 
administered by spray or aerosol might be jeopardized due to the use of tap water for reconstitution 63 













al., 1997), by large shear forces, which are applied to the liquid in order to transform it into droplets 65 
(Swift, 1985) and most importantly, due to inactivation of the vaccine virus by evaporation of 66 
droplets after generation (Gough & Allan, 1973; Landman & Van Eck, 2001; Yadin & Orthel, 67 
1978). It was hypothesized that these harmful effects might be overcome by formulating the 68 
vaccine in dry powder form with defined particle size, thereby improving vaccination efficiency. 69 
According to Huyge and others (Huyge et al., 2012) the ideal powder vaccine should meet the 70 
following requirements: (1) show no or only limited virus loss during production and storage; (2) 71 
be monodisperse; (3) consist of particles with a size that will enable exclusive targeting of the 72 
upper respiratory tract for primary vaccinations or the lower respiratory airways for secondary 73 
(booster) vaccinations; (4) be easy to disperse into their primary particle size; (5) be non-74 
hygroscopic to prevent hygroscopic growth of the vaccine virus loaded particles in the airways 75 
during respiration (Morrow, 1986); and (6) is non-toxic for man, animals and environment. In 76 
previous research ND powder vaccines based on mannitol and bovine serum albumin (BSA), 77 
which approximated mentioned requirements, were prepared in a one-step spray-drying process 78 
(Corbanie et al., 2007; Huyge et al., 2012). A preliminary proof of principle experiment showed 79 
that the powder vaccine formulations induced high haemagglutination inhibiting (HI) antibody 80 
titres in 4-week-old broilers (Corbanie et al., 2008). 81 
In the present study, LZ58 ND vaccine was administered to 4-days-old SPF broiler hens 82 
either as powder or as liquid (further referred to as powder vaccine and liquid vaccine). Vaccinal 83 
reaction and immune response induced by coarse (particle size intended to be between 20 and 84 
approximately 50 µm) and fine (particle size intended to be <5 µm) ND powder vaccines were 85 
compared with those provoked by their liquid counterparts. Powder vaccines were based on 86 












consisting of 90 wt% coarse and 10 wt% fine particles (further referred to as mixed powder 88 
vaccine) was included in the experiment to examine the effect of fine particle contamination of a 89 
coarse powder vaccine on vaccinal reaction. Vaccinal reactions in the field are characterized by 90 
respiratory distress, growth retardation and most importantly enhanced susceptibility to secondary 91 
bacterial infections especially Escherichia coli infections. The latter may result in colibacillosis. 92 
Therefore, the vaccinal reactions in the present study were monitored using the following 93 
parameters: clinical signs, body weight gain, mortality and colibacillosis lesions following 94 
inoculation of the birds with a virulent E. coli strain (Dho-Moulin & Fairbrother, 1999; Goren, 95 
1978, 1991; Gross, 1990; Van Eck & Goren, 1991). The immune response was determined by 96 
testing the sera of the birds two weeks after vaccination for HI ND antibodies. 97 
SPF broiler hens were used in this study as maternal antibodies interfere with the serum antibody 98 
response (Van Eck et al., 1991; Yadin, 1981). Further, broilers were chosen as they are more 99 
sensitive to colibacillosis than layers (Goren, 1991) and finally, birds of the same gender (hens) 100 
were used because body weight gain was one of the parameters for vaccinal reactions. 101 
Although no longer commercially available the LZ58 ND vaccine virus strain was administered 102 
as it induces stronger vaccinal reactions compared to the Ulster 2C and Clone 30 ND virus strains 103 
(Van Eck & Goren, 1991). E. coli inoculation was performed intratracheally (i.t.) as the natural 104 
route of infection is likely airborne (Goren, 1978). 105 













MATERIALS AND METHODS 107 
 108 
Experimental design and husbandry 109 
The experimental design is given in Table 1. Newly hatched (day of hatch is day 0) SPF broilers 110 
obtained from and hatched at GD (Animal Health, Deventer, the Netherlands) were cloacally sexed 111 
and subsequently eight groups of 40 hens each were formed. After individual tagging, groups were 112 
placed in separated negative pressure HEPA isolators (Beyer & Eggelaar, Utrecht, the 113 
Netherlands), with a volume of 1.38 m3. At four days of age, broilers were vaccinated either with 114 
powder vaccine (groups 4, 6 and 7) or with liquid vaccine (groups 5 and 8), further referred to as 115 
vaccine groups. At 11 days of age all vaccinated birds were i.t. inoculated with E. coli strain 506. 116 
Control groups (groups 1, 2 and 3) were included in the study. Group 1 served as negative control 117 
group; further referred to as the negative group, while groups 2 and 3 were given powders without 118 
vaccine virus (further referred to as placebo powders). Group 3 was E. coli inoculated and further 119 
referred to as E. coli group, while Group 2 received phosphate buffered saline (PBS) instead, 120 
further referred to as placebo group. 121 
All broilers were individually weighed at four, 11 and 18 days of age and body weight gain 122 
between day four and 11 and between day 11 and 18 was calculated. Groups of birds were 123 
inspected daily for disease signs and mortality. Dead birds were stored at -20°C until gross 124 
postmortem examination at the end of the experiment at 18 days of age at which time surviving 125 
birds were stunned using a mixture of CO2 and O2. Thereafter they were debleeded by incision of 126 
the vena jugularis and blood was collected for serology. Subsequently, birds were subjected to 127 
postmortem examination to assess colibacillosis lesion scores. Bacteriological examination was 128 
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performed on all birds that had died during the study and of a number of surviving birds of all 129 
groups (see post-mortem examination). 130 
Commercial broiler feed and tap water were provided ad libitum during the whole 131 
experiment. Up to eight days of age broilers were given 22 hours of light per day after which light 132 
was reduced to 16 hours per day. Isolator temperature was 35°C on day 0 and was gradually 133 
decreased to 25°C at day 18. 134 
 135 
Preparation of vaccines 136 
The coarse powder vaccine (intended particle size between 20 and approximately 50 µm) 137 
was produced by spray drying using a 4M8-TriX Procept spray dryer, kindly supplied by Procept 138 
(Zelzate, Belgium), equipped with a 25 kHz ultrasonic nozzle. The content of one vial with 139 
approximately 1010 50% egg infective dose (EID50) of LZ58 ND vaccine virus, kindly provided 140 
by Intervet-Schering Plough Animal Health (Boxmeer, the Netherlands), was suspended into 100 141 
ml of a 15% (wt/wt) solution in demineralised water containing 60 wt% mannitol (C*MannidexTM, 142 
Cargill, Krefeld, Germany) and 40 wt% BSA (Sigma-Aldrich, Steinheim, Germany). The vaccine 143 
suspension was then spray dried at an inlet temperature of 100°C and a feed rate of 2 ml/min, 144 
resulting in an outlet temperature of approximately 65°C. After production, the coarse powder 145 
vaccine was sieved through a micro-sieve of 20 µm (W 0.02 MM, Hosokawa Alpine, Cheshire, 146 
UK) using an air jet sieve (A200LS-N, Hosokawa Micron, Cheshire, UK) in order to minimize the 147 
particle fraction below 20 µm. 148 
The fine powder vaccine (intended particle size <5 µm) was produced by the Mobile Minor D-149 
2000 pilot plant spray dryer (GEA Niro, Soeborg, Denmark). Approximately, 1010 EID50 of LZ58 150 
ND vaccine virus (content of one vial) was dispersed into 1500 ml of a 1% (wt/wt) solution in 151 
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demineralised water containing 80 wt% mannitol (C*MannidexTM, Cargill, Krefeld, Germany) and 152 
20 wt% BSA (Sigma-Aldrich, Steinheim, Germany) and subsequently spray dried. The feed was 153 
atomized by a two fluid nozzle (∅= 1 mm) operating at an air flow of 113.9 l/min and dried at an 154 
inlet temperature of 120°C and a feed rate of 12 ml/min, resulting in an outlet temperature of 155 
approximately 65°C. 156 
During the production process, the powder recipients of the spray dryers were emptied every 10 157 
minutes in order to minimize vaccine loss by heat stress. Coarse and fine placebo powders were 158 
produced via the same processes as described earlier. 159 
To obtain the mixed powder vaccine, 4.5 g of sieved coarse powder vaccine was physically mixed 160 
with 0.5 g of fine powder vaccine. Placebo powders used in the experiment consisted of a mixture 161 
of coarse and fine placebo powders in a 1:1 weight ratio. 162 
Liquid vaccines used as coarse liquid spray and fine aerosol were prepared by suspending 163 
approximately 1010 EID50 of LZ58 ND vaccine virus (content of one vial) in 500 ml sterile 164 
demineralized water on the day of vaccination. 165 
 166 
Characterization of vaccines 167 
For virus titrations, 100 mg of each of the powder vaccines was dissolved into 1 ml 168 
Dulbecco’s phosphate buffered saline (DBPS, Invitrogen, Paisley, UK) with 1% penicillin-169 
streptomycin solution (penicillin G (10,000 IU/ml) – streptomycin sulphate (10,000 µg/ml)). 170 
Samples of liquid vaccines, which had been taken immediately after vaccination and subsequently 171 
frozen at -78°C by immersion of the sample containing test tubes (sterile polypropylene conical 172 
test tube, 15 ml, MEUS, Piove di Sacco, Italy) into a mixture of dry ice and 70% ethanol (Chemlab, 173 
Zedelgem, Belgium) and stored at -80°C until virus titration, were thawed at room temperature. 174 
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Ten-fold dilutions (10-3 – 10-9) of each suspension were made in DPBS with penicillin-175 
streptomycin and 0.1 ml of each dilution was inoculated into the allantoic cavity of 10-day-old 176 
embryonated SPF chicken eggs, using 4 eggs per dilution. After 72h of incubation at 37°C, the 177 
allantoic fluid was tested for haemagglutinating (HA) activity (Grimes, 2002). Virus titres were 178 
expressed as EID50, calculated according to the formula of Reed and Muench (Reed & Muench, 179 
1938). 180 
Particle and droplet size distributions were determined by a laser diffractor operating in 181 
open mode (Mastersizer-S, long bench; Malvern Instruments, Malvern, UK) and equipped with a 182 
300 mm lens using placebo powders and demineralized water, respectively. Dispersion was 183 
performed with the same equipment used to vaccinate the broilers. 184 
Powder samples were dispersed directly into the laser beam using an experimental air-assisted 185 
device consisting of an air compressor (OMRON CX3, Hoofddorp, the Netherlands) forcing air 186 
(10 l/min) into a glass Büchner flask (Schott Duran 100 ml, Mainz, Germany) and transporting the 187 
powder particles to the outlet of the flask through a plastic tube (Tygon Laboratory Tubing 188 
R3606, Saint-Gobain Performance Plastics, Akron (OH), USA) of 21 cm with an orifice opening 189 
of 2x10 mm.  190 
The fine liquid aerosol was generated by the Walther Pilot I spray-head with a 0.5 mm nozzle 191 
diameter (Walther Spritz-und Lackiersysteme, Wuppertal, Germany) attached to a compressor 192 
(Mecha Concorde type 7SAX, 1001, SACIM, Verona, Italy) operating at 2 bar. The coarse liquid 193 
vaccine was dispersed by manually actuating a hand-held spray bottle (Powerplus Garden POW 194 
63868, Varo, Lier, Belgium) at a frequency of 1 actuation per second. During the measurements 195 






During analysis, orifices of the dispersion equipment were held 4 cm from the laser beam and 4 198 
cm from the optic lens (Laboratory of Pharmaceutical Technology, Gent University, Gent, 199 
Belgium; ‘in house method’). All measurements were performed in triplicate and results were 200 
expressed as mean volume diameters D (v, 0.1), D (v, 0.5), D (v, 0.9) and span. Span was calculated 201 
as: 202 
𝑥𝑥 =
𝐷𝐷 (𝑣𝑣, 0.9) − 𝐷𝐷 (𝑣𝑣, 0.1) 
𝐷𝐷 (𝑣𝑣, 0.5)
 203 
Also, percentages of particles and droplets with a size below 1, 5, 10 and 20 µm were determined. 204 
Based on droplet size parameters D (v, 0.x), the size of dry particles obtained after complete 205 
evaporation of the droplets was estimated using the following equation, taking into account the 206 
content of dry matter in the droplets (1.25 mg/ml) and the density of the dry matter (assumed to be 207 
1000 mg/cm3): 208 




= 𝐷𝐷 (𝑣𝑣, 0. 𝑥𝑥) 𝑑𝑑𝑑𝑑𝑑𝑑𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 ∙ 0.108 209 
The dry matter content of the liquid vaccine was determined in threefold by drying a sample of 210 
known volume on a watch glass until constant weight (i.e. until ± 0.05 µg accuracy; analytical 211 
balance AG245, Mettler Toledo, Zaventem, Belgium) in an incubator (Memmert INP 600, 212 




Vaccination of the broilers was performed in the isolators in which they were housed. 217 
During vaccination the isolator ventilation was switched-off until 30 min after the end of vaccine 218 
dispersion. Temperature and relative humidity (RH) in the isolators were recorded every 2 seconds 219 
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by a temperature and humidity logger (Testostor 171-2, Testo, Ternat, Belgium) from the end of 220 
vaccine dispersion until 30 minutes thereafter. During this period the RH raised from 50–70% to 221 
65-80% at an average temperature ± SD of 30.4 ± 1.2°C. 222 
Five grams of powder vaccine or 5 ml of liquid vaccine was dispersed in the corresponding 223 
isolator aiming at a vaccine dose of approximately 108 EID50 per isolator. Powders and liquids 224 
were dispersed as described under characterization of vaccines. Coarse vaccines were applied 225 
beaming directly at the birds, while fine vaccines were dispersed in the air above the birds. 226 
 227 
Assessment of aerosol vaccine virus titres and estimation of inhaled vaccine dose per bird 228 
Aerosol sampling was performed using a Sartorius MD8 airscan (Sartorius B.V., 229 
Nieuwegein, the Netherlands) fitted with sterile gelatin filters with a pore size of 3.0 µm (17528-230 
80-ACD, Sartorius Stedim Biotech, Göttingen, Germany). The filters were held vertically at a 231 
height of 15 cm above the isolator floor. Each time, a sample was taken during 2 min at 2000 l/h 232 
resulting in a volume of 67 l. Samples were taken immediately after vaccine dispersion and 10 and 233 
20 min thereafter. Directly after sampling gelatin filters were each dissolved in 10 ml sterile DPBS 234 
(Invitrogen, Paisley, UK) kept at 37°C, frozen in a mixture of dry ice and 70% ethanol as described 235 
under preparation of vaccines and subsequently stored at -80°C until virus titrations, which were 236 
performed as described under characterization of vaccines with a few modifications. Samples 237 
thawed at room temperature were inoculated as 100 to 10-6 dilutions into five 10-day-old 238 
embryonated SPF eggs per dilution, using an inoculation volume of 0.3 ml per egg. Virus titres 239 
were expressed per m3 air, taking into account the dissolution volume of the gelatin filters (10 ml) 240 
and the sample volume (67 l). The detection limit was calculated following the minimal conditions 241 
necessary to be able to apply the formula of Reed and Muench (Reed & Muench, 1938) (i.e. 3 eggs 242 Field Code Changed
11 
 
with HA positive allantoic fluid out of 5 inoculated eggs with the lowest dilution (100)) and 243 
appeared to be 102.9 EID50 per m3 air. 244 
Initial vaccine virus loss defined as the difference between log10 vaccine dose per m3 air 245 
and log10 vaccine concentration of the aerosol per m3 immediately after ending of the vaccine 246 
dispersion, was calculated for each of the vaccine groups. 247 
To assess vaccine virus loss during sample processing (freezing-thawing) 100 mg of coarse 248 
powder vaccine was spread over a sterile gelatin filter. Subsequently, the filter was dissolved in 249 
10 ml DPBS of 38°C and half of this volume was frozen and thawed as described above and kept 250 
on melting ice together with the other non-frozen half until virus titration approximately two hours 251 
later. Additionally, virus titration of 1 g powder vaccine without gelatin dissolved in 10 ml PBS 252 
was performed. Vaccine virus titres per mg powder were 104.8, 105.0 and 105.3 EID50 for the powder 253 
vaccine without gelatin, the non-frozen and the frozen-thawed dissolved gelatin filter, respectively, 254 
indicating that freezing and thawing of dissolved filters has no effect on vaccine virus titres. 255 
The vaccine virus dose inhaled per broiler in the period from the start of vaccine dispersion 256 
until 30 min after the end of dispersion was estimated based on a ventilation rate of 1932 ml/min 257 
per kg body weight for 18-day-old broilers (Reeves et al., 1991). The following assumptions were 258 
made for the calculation of the vaccine virus-uptake: (1) all aerosol particles detected by air 259 
sampling are inhalable; (2) the increase and decline of the aerosol vaccine concentration in the 260 
isolator is linear; and (3) 30 min after the end of the vaccine dispersion the aerosol virus titres are 261 
considered to be ‘0’; also all aerosol virus titres below the detection limit are considered to be ‘0’; 262 
(4) vaccine retention by the birds is 100% (Hayter & Besch, 1974; Yadin, 1980). 263 
 264 






E. coli strain 506 (serotype O78K80) used is a flumequine resistant and doxycycline 266 
intermediary sensitive strain that was isolated from the inflamed pericardium of a broiler chick 267 
suffering from natural colibacillosis. Frozen beads (-70°C) containing this strain were submersed 268 
into 0.1% glucose broth (1000 ml purified water, 5 g Lab Lemco (Oxoid LP0029), 10 g 269 
bacteriological peptone (Oxoid LP0-037), 5 g NaCl (VWR 1.06404.1000, Merck) and 1 g glucose 270 
(VWR 1.08342.1000, Merck)), which was incubated during 17 hours at 37°C. This broth was 271 
diluted 1:5000 (v/v) in PBS and kept on melting ice during the inoculation procedure. Every bird 272 
received 0.3 ml i.t. One group (Group 2) was i.t. placebo inoculated with 0.3 ml PBS per broiler. 273 
I.t. inoculations were performed using a 1 ml syringe coupled to a knobbed curved stainless steel 274 
cannula of 1.5 X 45 mm (art.nr. 14186, AUV Group, Cuijk, the Netherlands). 275 
Determination of the bacterial concentration of the inoculum was performed by means of 276 
bacterial counting according to international standards using a sample taken at the start and at the 277 
end of the inoculation procedure. The inoculum contained 104.8 colony forming units (cfu) per ml 278 
both, at the start and the end of the inoculation procedure, resulting in a dose of 10 4.3 cfu per bird. 279 
 280 
Post-mortem examination 281 
Post-mortem examination was performed on all birds. The left and right thoracic air sacs, 282 
the pericardium and the liver were macroscopically examined for colibacillosis lesions, which was 283 
done blindly. The scoring (0 to 3 for each organ with a maximum score of 12 per bird) was 284 
performed according to Van Eck and Goren (Van Eck & Goren, 1991). The mean lesion score 285 
(MLS), the number and percentage of affected animals, and the number and percentage of birds 286 




affected when lesions were observed, while general colibacillosis was diagnosed when lesions 288 
occurred on the pericardium and/or the liver. 289 
The gender of each broiler was re-evaluated during post-mortem examination to correct the mean 290 
body weights for sex faults on day 0. 291 
Bacteriological examination of the bone marrow (femur) of all birds that died during the 292 
experiment (except for one bird of group 7 from which the affected pericardium was examined), 293 
supplemented with bacteriological examination of surviving birds to a maximum of 5 birds per 294 
group was performed. Of the latter birds affected pericardia or airsacs were bacteriologically 295 
examined. In case no colibacillosis lesions were observed (control groups), bone marrow was 296 
examined of five birds per group. 297 
Bone marrow from birds which died during the experiment was bacteriologically examined 298 
to determine the specificity of mortality. Mortality was considered specific in case dead birds 299 
showed generalized colibacillosis and/or E. coli was isolated from their bone marrow. 300 
Bacteriological examination was performed using sheep-blood agar plates (K004P090; 301 
Biotrading), which were incubated overnight at 37°C and thereafter visually inspected for purity. 302 
Biochemical identification of colonies was performed using the indole and β-glucuronidase test, 303 
which are both positive for E. coli.  304 
All reisolates and the inoculum strain were stored at -80°C for Pulsed-Field Gel 305 
Electrophoresis (PFGE). 306 
 307 
Serology 308 
Antibody titres to ND virus in sera of 24 surplus birds taken at day 0 and of all surviving 309 
birds at day 18 were assessed by HI test as described by De Jong (De Jong, 1978) using 8 HA units 310 Field Code Changed
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of Ulster vaccine virus and expressed as log2 titres. Titrations were performed until endpoint and 311 
all samples were analysed in one run. Titres <1 were given value 1 for the calculation of mean 312 
titres and statistical analyses. 313 
Log2 antibody titres at day 0 were <1 confirming the SPF status of the broilers. 314 
 315 
PFGE 316 
The clonal relationship between reisolated E. coli bacteria and the inoculated E. coli strain 317 
was analysed by PFGE. 318 
The PFGE-technique of contour-clamped homogeneous electric fields (CHEF) was used 319 
for genomic typing of the E. coli bacteria (one colony per positive sample). Genomic DNAs were 320 
digested in agarose plugs with Xba I (10 U)(Roche Diagnostics, Mannheim, Germany). The 321 
resulting fragments were resolved by CHEF-PFGE with a CHEF-DR III apparatus (Bio-Rad 322 
Laboratories, Richmond (CA), USA) at a constant voltage of 6 V/cm for 20 h at 14ºC, an included 323 
angle of 120º and an initial and final switch time of 2.2 and 54.2 seconds, respectively. The 324 
generated fingerprints were processed using BioNumerics software (Applied Maths NV, Sint-325 
Martens-Latem, Belgium). The similarity was calculated using the band-based DICE coefficient 326 
with 1% optimization and 1% tolerance. Clustering was performed by the unweighted pair method 327 
with arithmetic averages (UPGMA). Isolates were considered ‘indistinguishable’ if 100% of the 328 
fragments were identical. 329 
 330 
Statistics 331 
Survival rates of groups were compared using the Mantel-Cox log-rank test. Body weights 332 
at day 4 and body weight gain between 4 and 11, and between 11 and 18 days of age were compared 333 
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with one-way ANOVA followed by the post-hoc Scheffé’s test after verifying the normality of 334 
residuals with a Q-Q plot and homogenicity of variances with the Levene’s test. Survival analysis 335 
and body weight analysis were performed in SPSS version 20 (IBM, New York, USA). 336 
Comparison of serum antibody titres and E. coli scores between the eight groups was performed 337 
using the Kruskal-Wallis test. Pairwise comparisons were carried out using Wilcoxon rank sum 338 
test, adjusting the p-values for the number of performed tests with the Bonferroni correction. 339 
Numbers of birds affected by colibacillosis and with generalized colibacillosis were compared 340 
between groups by fitting a logistic regression with infection as response and vaccination as 341 
explanatory variable. All analyses were performed in R (version 2.14.1, the R Foundation for 342 
Statistical Computing) unless specified differently. P <0.05 was used as significance level. 343 
 344 
Ethics 345 
The study was approved by the Institutional Animal Experimental Committee, DEC-Consult 346 







Vaccine characteristics 352 
Virus titres of the powder and liquid vaccines ranged from 107.5 to 107.7 EID50 per gram 353 
and from 107.8 to 107.9 EID50 per ml, respectively (Table 2), resulting in a dosis per m3 isolator air 354 
(5 g or 5 ml vaccine was used per isolator) ranging from 108.1 to 108.5 EID50 (Table 3). 355 
Average particle/droplet size distributions and distribution spans of the vaccines are presented in 356 
Table 4. The percentages of particles and droplets with a diameter below 20, 10, 5 and 1 µm and 357 
their corresponding vaccine virus titres per g or ml vaccine are presented in Table 2. 358 
The median volume diameter (D(v,0.5)) of the coarse vaccine powder particles and of the 359 
droplets of the coarse liquid vaccine were 37 and 106.4 µm, respectively. Dry particles originating 360 
from droplets of the coarse liquid vaccine had a (D(v,0.5)) of 11.5 µm. Ninety percent of the 361 
particles of the coarse vaccine powder had a size below 55 µm, while the same percentage of the 362 
coarse liquid spray was present in droplets <300 µm. Spans of the coarse powder particle size 363 
distribution, the droplet size distribution of the coarse liquid spray and of the dry particles 364 
originating from droplets of the coarse spray were 0.8, 2.5 and 2.5, respectively (Table 4). 365 
The coarse powder vaccine contained 4.4% particles smaller than 20 µm (virus titre in this 366 
fraction 106.3 EID50 g vaccine) and <0.01% particles smaller than 5 µm (virus titre in this fraction 367 
<103.7 EID50 g vaccine). The coarse spray consisted of 0.52% of droplets below 5 µm; following 368 
evaporation of the coarse spray droplets the percentage of dry particles below 5 µm was 17.8 369 
(Table 2). 370 
The fine powder vaccine particles and the droplets of the fine aerosol had a similar D(v,0.1) 371 
(2.6 and 2.7 µm) and D(v,0.5) (6.5 and 10.0 µm), but a highly different D(v,0.9) (13.8 µm for the 372 
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fine powder vaccine and 237 µm for the fine liquid vaccine) resulting in substantially different 373 
spans (fine powder particles 1.7; fine aerosol droplets 23.5) (Table 4). The fine powder vaccine 374 
consisted of 35.3% of particles smaller than 5 µm (virus titre in this fraction 107.0 EID50 g vaccine) 375 
and of 2.8% of particles below 1 µm (virus titre in this fraction 105.9 EID50 g vaccine), while 83.7% 376 
and 49.6% of dry particles originating from fine aerosol droplets were below 5 and 1 µm, 377 
respectively (Table 2). 378 
In general, particle size distribution of the mixed powder vaccine was in between that of 379 
the coarse and fine powder vaccine (tables 2 and 4). The percentages of particles smaller than 1, 380 
5, 10 and 20 µm in the mixed powder vaccine were clearly below those of the fine powder (0.80, 381 
5.0, 8.0 and 15.2% in the mixed powder vaccine, respectively versus 2.8, 35.3, 76.9 and 91.7% in 382 
the fine powder vaccine, respectively). However, differences in log10EID50 vaccine virus titres in 383 
mentioned fractions of the vaccines were small (5.6, 6.4, 6.6 and 6.9 in the mixed powder vaccine, 384 
respectively versus 5.9, 7.0, 7.4 and 7.5 in the fine powder vaccine, respectively). 385 
The percentage of particles below 1 µm in the mixed powder vaccine and the percentage 386 
of dry particles below 1 µm originating from the coarse vaccine droplets were almost equal (0.80 387 
versus 0.81), while the percentages of particles below 5, 10 and 20 µm in the mixed vaccine 388 
powder (5.0, 8.0 and 15.2%, respectively) were below those of the dry particles originating from 389 
the coarse vaccine droplets (17.8, 44.7 and 76.1%, respectively) (Table 2). 390 
 391 
Aerosol vaccine virus titres and estimated inhaled vaccine dose per bird 392 
Vaccine doses per m3 air, aerosol vaccine titres, initial virus losses and estimated vaccine doses 393 
inhaled per broiler are presented in Table 3. Vaccine virus was not detected in air samples taken 394 
after dispersion of placebo powders (groups 2 and 3). Although vaccine doses did not differ 395 
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substantially between vaccine groups (108.1 to 108.5 EID50 per m3 air) airborne virus titres did, 396 
depending on the vaccine type. Lowest initial virus titre losses occurred after dispersion of fine 397 
and mixed powder vaccines (1.0 log10 and 2.4 log10, respectively). These vaccines produced the 398 
highest airborne virus concentrations: 107.1 and 105.9 EID50 per m3 air for the fine and mixed 399 
powder vaccine respectively immediately after dispersion, thereafter decreasing to 104.4 and 103.2 400 
EID50 per m3 air at 20 min after dispersion, respectively. Calculated inhaled doses of these 401 
vaccines were 104.3 and 103.0 EID50 per broiler. 402 
Coarse vaccines showed highest initial virus losses (4.1 log10 and 5.4 log10 for powder and liquid 403 
vaccine, respectively) and lowest airborne concentrations (104.2 EID50 per m3 air for the powder 404 
vaccine and 103.0 EID50 per m3 air for the liquid vaccine, directly after nebulization), thereafter 405 
decreasing to the detection limit (102.9 EID50 per m3 air) or below resulting in the lowest inhaled 406 
vaccine virus doses per bird (101.3 EID50 (= 20 EID50) for the powder vaccine and 10-0.1 EID50 (= 407 
0.8 EID50) for the liquid vaccine). 408 
The fine liquid vaccine gave an initial vaccine virus loss and airborne virus titres between the fine 409 
and mixed powder vaccine on one side and the coarse vaccines on the other side.  410 
The estimated inhaled vaccine dose per bird was 102.5 EID50. 411 
 412 
Vaccinal reactions and serum antibody response 413 
Clinical signs of disease were not observed in birds of the negative, placebo and E. coli group, 414 
moreover antibodies to ND virus were not detected in these birds. Slight depression was observed 415 
in all vaccine groups from 6 days after vaccination, being somewhat more severe in groups 416 
vaccinated with the fine and mixed powder and the fine liquid vaccine (groups 6, 7 and 8). 417 
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Two to four broilers in each of the groups in which the fine vaccines or the mixed powder vaccine 418 
was administered (groups 6, 7 and 8) showed mouth breathing from 6 to 8 days following 419 
vaccination. This was not observed in the other vaccine groups (groups 4 and 5). 420 
After E. coli inoculation clinical signs of depression increased in all vaccine groups (groups 4 to 421 
8) and these signs were observed thereafter until the end of the experiment. 422 
Values of parameters of vaccinal reaction other than clinical signs (mortality, body weight 423 
gain (BWG) and colibacillosis lesions) are presented in Table 1. No significant differences (P 424 
>0.05) regarding these parameters were found between the control groups (groups 1, 2 and 3). 425 
Mortality, which only occurred after E. coli inoculation, ranged from 2 to 4 broilers per 426 
group; differences between groups were not significant (P >0.05). All mortality was specific, i.e. 427 
due to colibacillosis. 428 
Mean body weight ± SD of broilers at day 4 (day of vaccination) ranged from 85 ± 6 to 91 429 
± 6 g between groups. Differences were not significant (P >0.05). 430 
All vaccine groups (groups 4 to 8) showed growth retardation and a significantly (P <0.05) 431 
higher number of birds with colibacillosis, which was also more severe in comparison with birds 432 
of the E. coli group (Group 3). Growth retardation occurred in both, the week after vaccination 433 
(day 4 to day 11) and the week after E. coli inoculation (day 11 to day 18), but was more 434 
pronounced in the latter period. 435 
BWG ± SD of vaccinated broilers (groups 4 to 8) between 4 and 11 days of age, and between 11 436 
and 18 days of age ranged from 131 ± 27 g to 154 ± 18 g and from 126 ± 42 g to 160 ± 35 g, 437 
respectively. In the same periods BWG ± SD of the E. coli group (Group 3) was 161 ± 16± g and 438 
189 ± 54 g, respectively. 439 
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In vaccine groups (groups 4 to 8) 68 to 97% of the birds showed colibacillosis lesions and the MLS 440 
ranged from 1.7 to 4.9, while the values of these parameters in the E. coli group were 3% and 0.2. 441 
Coarse vaccines (groups 4 and 5) induced less growth retardation, significantly (P <0.05) 442 
less colibacillosis and significantly (P <0.05) lower HI ND virus titres compared to the fine 443 
vaccines (groups 7 and 8). 444 
Generalized colibacillosis hardly occurred in broilers vaccinated with the coarse vaccines (groups 445 
4 and 5; 3 to 5%), while substantial numbers of birds with this condition were present in groups 446 
vaccinated with the fine vaccines (groups 7 and 8; 15 to 28%). 447 
Coarse vaccines (groups 4 and 5) induced mean log2 HI ND virus titres of 3.2 to 3.4; the fine 448 
vaccines (groups 7 and 8) of 4.4. to 5.2. The highest mean HI titre (5.2) was found in broilers 449 
vaccinated with the fine liquid vaccine (group 8). 450 
No significant differences were seen between vaccinal reaction parameter values of birds 451 
given the fine vaccines (groups 7 and 8) and those vaccinated with the mixed powder vaccine 452 
(Group 6). The serum antibody response of broilers vaccinated with the mixed powder vaccine 453 
(mean log2 HI ND virus titre is 4.3) was almost equal to that of broilers that received the fine 454 
powder vaccine (Group 7: mean log2 HI ND virus titre is 4.4), but was significantly below the 455 
response of birds supplied with the liquid aerosol (Group 8: mean log2 HI ND virus titre is 5.2). 456 
Significant differences in values of vaccinal reaction parameters and seroresponse were 457 
neither observed between broilers vaccinated with coarse powder (Group 4) and coarse liquid 458 
vaccine (Group 5) nor between fine powder (Group7) and fine liquid vaccine (Group 8). 459 
 460 
Bacteriological analysis and PFGE 461 
Bacteria were not isolated from the bone marrow of birds of the negative and the placebo groups. 462 
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E. coli was isolated from the bone marrow of 16/17 broilers that died during the experiment, while 463 
it was isolated from pericardium of one dead bird (group 7) of which the bone marrow was not 464 
examined. E. coli was also isolated from 9/13 surviving birds of which affected organs 465 
(pericardium or airsac) were bacteriologically examined. 466 
PFGE of the 26 E. coli colonies revealed that, except for one colony from an airsac (group 5) all 467 
colonies were clonal and showed 100% similarity to the parent strain used in this study. The 468 
reference strains isolated from the bone marrow of layers with E. coli peritonitis syndrome (EPS) 469 
were not genetically related to the parent strain and the reisolates (similarity <85%). 470 




In the present study, we hypothesized that the coarse powder vaccine aimed at targeting 473 
exclusively the upper respiratory tract, would provoke less vaccinal reaction while retaining a 474 
satisfactory immune response in comparison with coarse liquid vaccine and that the fine powder 475 
vaccine would increase the seroresponse due to a lower loss of vaccine virus in the aerosol in 476 
comparison with the fine liquid vaccine. The latter, likely due to the absence of virus inactivation 477 
by formation and evaporation of droplets, was shown in previous research (Corbanie et al., 2008). 478 
However, neither a decreased vaccinal reaction using the coarse powder vaccine, nor an increased 479 
seroresponse after vaccination with the fine powder vaccine was found. 480 
Although it was intended to produce a coarse powder vaccine with particles >20 µm to prevent 481 
respirability, 4.4% had a diameter below this value. Regarding the fine powder vaccine our 482 
intention was to manufacture a powder with particle sizes below 5 µm, which was achieved only 483 
for 35.3% of the powder mass.  484 
Estimated inhaled vaccine doses were 20 and 0.8 EID50 per bird for the coarse powder and 485 
coarse liquid vaccine, respectively, which seems very low. If the calculated inhaled doses are real 486 
and only a part of the afore mentioned doses is respirable, the amount of vaccine virus deposited 487 
in the deeper airways will be even smaller. In this case there will be hardly any room to improve 488 
the coarse powder vaccine regarding its exclusive deposition in the upper respiratory tract. 489 
However, it is also possible that the inhaled doses have been underestimated. Plausible reasons for 490 
underestimation are: 1. The ventilation volume used corresponded to 18-day-old broilers and may 491 
have been relatively higher in younger birds. 2. The increase and decrease of airborne vaccine 492 
virus concentrations is not linear and the virus concentration below the detection limit is not 493 




the order of magnitude of a factor 2 to 3, this would not result in substantial differences in virus 495 
inhalation. 3. Inefficient capturing of particles with a size below the pore size of that of the gelatin 496 
filters (<3 µm), however this is not of importance as the retaining efficiency of airborne particles 497 
of 0.01 to 0.9 µm proved to be >93% (Clark Burton et al., 2007), while particles sized 0.5 to 3.0 498 
µm were collected with an efficiency of 99.9% (Koller & Rotter, 1974). 4. Loss of virus in the 499 
gelatin filters and/or due to processing of the filters (snap freezing and thawing), however this does 500 
not play a significant role as shown in the present study. 5. The dispersion or spraying of coarse 501 
vaccines directly on the birds may have resulted in temporary relative high local concentrations of 502 
vaccine virus close to the birds, which were not or incompletely detected by air sampling. The 503 
latter seems the most plausible explanation for underestimation. 504 
Whether coarse powder vaccines can be ameliorated regarding its vaccinal reaction inducing 505 
potency while retaining sufficient immunogenicity, is subject of current research. 506 
The fine powder vaccine showed lower virus loss during dispersion compared to fine liquid 507 
vaccine ) and persistence of the vaccine virus titre was highest in the powder aerosol (Table 3), 508 
which confirms earlier results (Corbanie et al., 2008). Consequently, highest inhaled vaccine doses 509 
were estimated for the fine powder vaccine (Table 3). However, although not significantly 510 
different, highest HI ND titres were measured in broilers vaccinated with the fine liquid vaccine 511 
(Table 1). This is likely due to the relative high percentage of very small dry particles (<1 µm) in 512 
the liquid vaccine virus aerosol, which originate from droplets due to evaporation (Table 2). 513 
Obviously this high percentage of very small particles contained sufficient live vaccine virus to 514 
induce a strong serum response after penetrating into the deepest tissues of the lower respiratory 515 
tract (atria and air capillaries) (Corbanie et al., 2006; Gough & Allan, 1973) despite virus 516 








Therefore, it is concluded that the strongest immune response likely can be obtained by vaccine 518 
particles of <1 µ, which is in agreement with the results of previous aerosol experiments with 519 
inactivated ND vaccines (Van Eck, 1990). However, considering the current state of the art in 520 
pharmaceutical technology, it seems almost impossible to manufacture a live vaccine virus 521 
containing dry powder that (mainly) consists of particles <1 µm. 522 
The mixed powder vaccine consisted of 90 wt % coarse powder vaccine and 10 wt % fine 523 
powder vaccine, thus can be considered as a fine powder vaccine with a virus titre 1log10 lower 524 
than that of the vaccine that only contained fine particles. This difference in vaccine virus titres 525 
was reflected in the estimated inhaled doses (Table 3), but did not result in significantly different 526 
vaccinal reactions nor in significantly different seroresponses (Table 1). Obviously a dose of 527 
103.0 EID50 vaccine virus per broiler already provoked the maximal reaction of the bird. 528 
The mixed powder vaccine can also be considered as a coarse vaccine ‘contaminated’ by 10 wt% 529 
fine powder vaccine. The foregoing illustrates that a contamination of mentioned magnitude is 530 
detrimental for the desirable properties (exclusive deposition in the upper airways) of the coarse 531 
powder vaccine. 532 
The percentages of dry particles <1, <5, <10 and <20 µm, which originate from coarse spray 533 
droplets by evaporation were equal or even greater than those of the mixed powder vaccine (Table 534 
2). Nevertheless, the coarse liquid spray induced clearly less vaccinal reaction and a weaker 535 
seroresponse compared to the mixed powder vaccine (Table 1). This is likely due the (almost) 536 
complete absence of live vaccine virus in the small dry particles from the coarse liquid vaccine 537 
due to inactivation by formation and evaporation of the droplets from which these small dry 538 
particles emerge. Sufficient live vaccine virus to provoke a strong seroresponse and vaccinal 539 




in contrast to the amount of live vaccine virus in dry particles of these sizes originating from the 541 
coarse liquid spray. An explanation for this may be the difference in mass in small dry particles 542 
between both vaccine types: high percentages from the fine liquid aerosol versus relative low 543 
percentages from the coarse liquid spray (Table 2). 544 
It is common knowledge that ND vaccines induce vaccinal reactions characterized by 545 
respiratory distress, growth retardation and increased susceptibility to colibacillosis. It is also 546 
known that birds exposed to the vaccine per aerosol show more severe respiratory disease signs 547 
and growth depression compared to spray exposure (Bermudez & Stewart-Brown, 2008; Guittet 548 
et al., 1997). Even mortality may occur after aerosol administration of ND vaccines to young 549 
chickens due to suffocation resulting from obstruction of the trachea bifurcation (Van Eck & 550 
Goren, 1991). The occurrence of respiratory distress and growth retardation inversely proportional 551 
to the size of vaccine particles was confirmed again in the present study. Moreover, it was also 552 
shown that vaccination with the fine vaccines increased the susceptibility to colibacillosis 553 
significantly more than vaccination with the coarse vaccines. Although this phenomenon was not 554 
unexpected, it is a novel finding. In comparison to broilers given the coarse vaccines, generalized 555 
colibacillosis occurred to a much greater extent after vaccination with the fine vaccines. From the 556 
present and other studies, it appears that generalized colibacillosis is very detrimental to broilers 557 
as it is associated with mortality and severe growth retardation (Matthijs et al., 2005; Matthijs et 558 
al., 2003; Peek et al., 2013), while only a minority of birds recover (Peek et al., 2013). 559 
In the present study it was confirmed once more that an inhaled dose of about 100 to 1000 560 
EID50 ND vaccine virus per bird administered via fine particles is able to induce excellent serum 561 
antibody responses in SPF broilers (Corbanie et al., 2008; Kohn, 1955; Van Eck & Goren, 1991). 562 













antibodies a lower antibody response will likely be obtained (Davelaar & Kouwenhoven, 1977; 564 
Gough & Allan, 1976; Van Eck et al., 1991). 565 
In conclusion, it can be stated that in the present laboratory experiment the coarse and fine 566 
powder vaccines did not differ significantly from their liquid counterparts in terms of vaccinal 567 
reaction and seroresponse. The room for improvement of the coarse powder vaccine is subject of 568 
on-going research. Unfortunately, possibilities to ameliorate the fine powder vaccine at seem to be 569 
out of reach at present. 570 
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